REPORT HIGHLIGHT
The paper diagnostics market is estimated to represent a global market of USD 6.53 billion by 2019 with growth rate of 8.1%.

Market Dynamics

The traditional method for analyzing vital parameters such as glucose, oxygen level, and pH involves drawing of patient’s blood and was sent to the laboratory for analysis. Paper diagnostic technique presents a unique opportunity in analyzing these parameters with the simple, cost-effective and non-invasive method. This technology enables an individual to check vital parameters in-home facilities, and in remote areas. Continuous increase in incidences of communicable and non-communicable diseases such as cancer, tuberculosis, and HIV is considered to be a high impact rendering driver for this industry growth.

For example, as per the World Health Organization (WHO), cancer is considered to be one of the leading causes of mortality and morbidity globally. The organization stated that in 2012 around 14 million cancer cases were recorded across the globe. Paper-based systems offer a simple, affordable and easy method in these disease diagnosis, augmenting the market growth. Other factors such as rising demand for homecare, technological advancements, and increasing government support stimulate the product demand to some extent. However, increasing product recalls is anticipated to hamper user confidence hence pull back the market growth.

Product Takeaway

In terms of products, the global paper diagnostics market is divided as Dipsticks, and Lateral Flow Assays. Around 64% share of the total market is captured by lateral flow assays which are expected to maintain its dominance over the study period. During the year 2021-2027, this segment is projected to capture more than 66% share of the total industry. These assays are widely used in terms of pregnancy tests. High growth of this segment is majorly attributed to the growing demand for miniaturized and non-invasive diagnostic procedures. Furthermore, associated benefits such as improved clinical sensitivity & specificity, better patient compliance, and cost reduction are expected to stimulate the segment growth significantly.

COVID-19 Impact and Recovery Analysis
This is a latest paper diagnostics market report, covering the current COVID-19 impact on the market. The pandemic has affected every aspect of life globally. This outbreak has brought along several changes in paper diagnostics market conditions. The rapidly changing market scenario and initial and future assessment of the COVID impact is covered in the published paper diagnostics report. It covers the entire study with an in-depth analysis on revenue growth and possible growth prospect in future. The report also delivers on key players along with strategic standpoint pertaining to price and promotions.

Regional Takeaway

In terms of geography, North America dominated the global market with 42.67% share in 2019. Increasing prevalence of infectious diseases such as tuberculosis, hepatitis, and HIV is expected to stimulate the rapid and effective diagnostic methods, augmenting the growth of this industry. For example, according to the Centres for Disease Control and Prevention data, in 2016, around 9,272 tuberculosis cases were recorded.

As a result, organizations such as the National Institute of Allergy and Infectious Diseases (NIAID) invest considerably to increase awareness about infectious diseases treatment and prevention among the patient population in the U.S. This would, in turn, boost the utilization of paper diagnostic techniques, driving the industry demand. On the contrary, Asia Pacific market is projected to grow with faster CAGR during the study period. Technological advancements such as a combination of nanotechnology with paper diagnostics, aging population, and increasing chronic disease incidences are considered to be a primary driving factor for the regional growth.

Key Vendor Takeaway

Major players operating in this industry include BiognostiX, Alere Inc., Siemens Healthcare, and Bio-Rad Laboratories. Introduction of technologically advanced products and strategic collaborations are considered to be a key parameter for being competitive in this industry. It is noted that established companies are actively engaged in strategic engagements to expand their product offering. For example, in July 2013, Diagnostics For All collaborated with MC10 in order to develop disposable, reader-less and quantitative paper-microfluidic device to measure micronutrients accurately.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PAPER DIAGNOSTICS MARKET, BY PRODUCT
Dipsticks
Lateral Flow Assays

GLOBAL PAPER DIAGNOSTICS MARKET, BY DEVICE TYPE
Diagnostics
Monitoring

GLOBAL PAPER DIAGNOSTICS MARKET, BY APPLICATION
Food quality testing
Environmental monitoring
Clinical Diagnostics

GLOBAL PAPER DIAGNOSTICS MARKET, BY DISEASE TYPE
Infectious diseases
Cancer
Liver Disorders
Others

GLOBAL PAPER DIAGNOSTICS MARKET, BY END USE
Research Laboratories
Home Healthcare
Hospital Settings

GLOBAL PAPER DIAGNOSTICS MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America